VSBC Gross Margin

As of 2025-05-30, the Gross Margin of Vitaspring Biomedical Co. Ltd (VSBC) is 36.9%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

VSBC Gross Margin - Historical Value

Date	Value
2022-01-31	36.9%
2021-01-31	44%
2020-01-31	0%
2019-01-31	50%
2018-01-31	50%
2017-01-31	-
	-
	-
	-
	-

VSBC Gross Margin - Peers Comparison

Ticker	Name	Value
ABVC	ABVC Biopharma Inc	99.9%
ANGN	Angion Biomedica Corp	100%
BGLC	BioNexus Gene Lab Corp	13.6%
CISO	CISO Global Inc	14.7%
CNWHF	China Networks International Holdings Ltd	36.3%
CYIO	CYIOS Corp	47.3%
DRVD	Driven Deliveries Inc	34.4%
ENZC	Enzolytics Inc	7775.2%
ETHC.NE	Ether Capital Corp	3.5%
ETI.CN	EnviroMetal Technologies Inc	-6.1%
EZOO	Ezagoo Ltd	-59.5%
FUST	Fuse Group Holding Inc	95%
HAVN.CN	HAVN Life Sciences Inc	32.4%
INND	InnerScope Hearing Technologies, Inc.	59.4%
LABP	Landos Biopharma Inc	7775.2%
MGRO.CN	MustGrow Biologics Corp	-
NUKK	Nukkleus Inc	16.9%
RAMM.CN	Ramm Pharma Corp	40.6%
RAYT	Rayont Inc	48.7%
SEAV	SEATech Ventures Corp	23.3%
SMKG	Smart Card Marketing Systems Inc	13.6%
TAAL.CN	TAAL Distributed Information Technologies Inc	54.4%
TLIS	Talis Biomedical Corp	98.1%
VIVK	Vivakor Inc	11.4%